A Maryland pathologist and MedChi past president explains how all-or-nothing contracts, anti-steering clauses and private equity deals inflate costs. He also outlines the federal and state reforms that could restore competition.
Eric Wargotz, MD, FCAP
Advertisement
Eric Wargotz, MD, FCAP, is a practicing physician, a pathologist based in Maryland, a clinical professor emeritus of pathology at the George Washington University School of Medicine, and the 178th president of MedChi, The Maryland State Medical Society.
Articles by Eric Wargotz, MD, FCAP
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Medical Economics
1
Kansas executive sentenced in Medicare brace scheme; teen vaping's gender gap flips; sticker shock in the nursery — Morning Medical Update
2
How unbundled maternity care codes could change OB/GYN pay in 2027
3
Medicaid work requirements: 44% of members unprepared, survey finds
4
10 numbers show resident pay still falls short
5